Stocktoria
Celcuity Inc. CELC
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2017-09-20
Chart by TradingView
4/9
Piotroski F — financial health
0.6
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$172.2M | -$113.3M | -$66.2M | -$39.4M | -$28.4M |
| Net income | -$177.0M | -$111.8M | -$63.8M | -$40.4M | -$29.6M |
| Operating cash flow | -$153.3M | -$83.5M | -$53.8M | -$36.0M | -$20.3M |
| Free cash flow | -$153.5M | -$83.7M | -$53.9M | -$36.2M | -$20.4M |
| Total assets | $466.6M | $245.1M | $191.2M | $175.7M | $85.9M |
| Total liabilities | $366.0M | $129.5M | $51.5M | $41.9M | $17.2M |
| Shareholders' equity | $100.6M | $115.6M | $139.8M | $133.8M | $68.7M |
| Ratios | |||||
| Return on assets | -37.9% | -45.6% | -33.4% | -23.0% | -34.5% |
| Return on equity | -176.1% | -96.7% | -45.6% | -30.2% | -43.1% |
| Debt / equity | 1.37× | 0.91× | 0.27× | 0.27× | 0.23× |
| Current ratio | 10.55 | 7.71 | 13.43 | 25.46 | 34.06 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 320,024 | $36.5M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.6 (distress)
- Working capital / assets 0.903
- Retained earnings / assets -0.962
- EBIT / assets -0.369
- Equity / liabilities 0.275
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001603454 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.